MARATTO

article · ACS Omega

Functionalization of Nanodiamond Surfaces with Metal β-Diketonato Complexes with Possible Application in Cancer Treatment

Abstract

Nanodiamonds (NDs) are used more frequently as drug carriers through absorption or chemical modification. In this report, we describe the chemical binding of metal β-diketonato complexes onto the ND surface using an aminosilane linker. The metals used were iron(III) and copper(II), with β-diketones, acetylacetone, trifluoroacetylacetone, and the naturally occurring curcumin, which is known for its biological activity. Improved cytotoxicity was observed with metal complexes bound to the drug carrier compared to the free metal complexes as a result of increased stability when bound to a carrier. The curcumin-containing copper(II) conjugate demonstrated an IC<sub>50</sub> of 1.85 μM against the HeLa cell line and showed no toxicity in a larval zebrafish bioassay.

Research topics

  • Diamond and Carbon-based Materials Research
  • Fullerene Chemistry and Applications
  • Carbon Nanotubes in Composites

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1021/acsomega.4c06835

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.